Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2.
about
Olomoucine II, but not purvalanol A, is transported by breast cancer resistance protein (ABCG2) and P-glycoprotein (ABCB1)Targeting multidrug resistance in cancerGlutamine residues in Q-loops of multidrug resistance protein MRP1 contribute to ATP binding via interaction with metal cofactorBenzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators.Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team upHydrogen-bond formation of the residue in H-loop of the nucleotide binding domain 2 with the ATP in this site and/or other residues of multidrug resistance protein MRP1 plays a crucial role during ATP-dependent solute transportMechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment.Importance of the difference in surface pressures of the cell membrane in doxorubicin resistant cells that do not express Pgp and ABCG2.Effect of cysteine mutagenesis on the function and disulfide bond formation of human ABCG2.Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells.Genetic variants contributing to daunorubicin-induced cytotoxicityABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan.Effects of putative catalytic base mutation E211Q on ABCG2-mediated methotrexate transport.Ligand-based targeted therapy for cancer tissue.Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics.Regulation of function by dimerization through the amino-terminal membrane-spanning domain of human ABCC1/MRP1.Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review.Progesterone receptor downregulates breast cancer resistance protein expression via binding to the progesterone response element in breast cancer.Genetic Variations in ABCG2 Gene Predict Breast Carcinoma Susceptibility and Clinical Outcomes after Treatment with Anthracycline-Based ChemotherapyPhotochemical internalisation of chemotherapy potentiates killing of multidrug-resistant breast and bladder cancer cells.PharmGKB summary: very important pharmacogene information for ABCG2.Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats.
P2860
Q28534229-FC1CCE20-1B62-40C1-BF25-449E85BB556BQ29616803-89E28B6C-D96F-43BE-A034-0B79C6AD5AE1Q34969885-472B6D3E-E424-4D4C-B023-C3F4B4139645Q35181940-21327301-5B72-4550-ACFB-67D0E0170E28Q35720625-5C4A0482-3195-4591-83B1-D552B7A5E502Q35742010-AE68F3E9-7558-4BE7-8EEE-FEBC464EBD78Q36120816-9E5733BB-A0F5-4DE2-81F1-4507D0FCE084Q36388185-4CF646EA-7D41-422D-9D34-25747BDCB9BEQ37054441-60D140F2-1634-448F-8870-3CA4D1916C12Q37076043-9058E1A4-EF7B-43FF-A31A-490DD8D30D08Q37112491-4182B6BF-A790-40DC-82E3-D728EAF279B8Q37271466-E666EF5A-9C9C-486C-855F-3F30591021E8Q37287637-BEC86B6D-1FEC-4464-B123-DF3D20B4448FQ37405445-F427D00C-A618-4E52-AE41-603E636C0A98Q37425224-B79FD342-A4C8-4573-B5DF-AD1DF4A805E2Q37885883-6278121F-0FC2-4BB5-A7D8-C36719942CC8Q38305242-C05C749B-D6F3-4ED5-A419-3DE7B88BA9B0Q38933314-F325A6C4-F755-45F9-884A-4AAF3F5CA549Q39393941-4CCC2DAE-39B1-4946-95A5-BF160D5C039BQ41075251-8ECE13FF-D0F8-4954-AF8C-81A6C84F1AADQ41847288-149BAA54-EE30-4A5F-AC57-79DA12435D3FQ46018199-BA7DE1A3-2058-413D-9523-132C503D0312Q46725859-1585A0D2-014A-4FA8-8155-58B19A38B36F
P2860
Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Multidrug resistance in cancer ...... ng cassette transporter ABCG2.
@ast
Multidrug resistance in cancer ...... ng cassette transporter ABCG2.
@en
type
label
Multidrug resistance in cancer ...... ng cassette transporter ABCG2.
@ast
Multidrug resistance in cancer ...... ng cassette transporter ABCG2.
@en
prefLabel
Multidrug resistance in cancer ...... ng cassette transporter ABCG2.
@ast
Multidrug resistance in cancer ...... ng cassette transporter ABCG2.
@en
P356
P1476
Multidrug resistance in cancer ...... ng cassette transporter ABCG2.
@en
P356
10.2174/1568011043482205
P577
2004-01-01T00:00:00Z